Skip to main content

Prevent Standardized Waitlist Ratio (PSWR)

CBE ID
3719
Endorsed
Endorsement Status
Not Endorsed
1.1 New or Maintenance
New
E&M Cycle
Fall 2022
Is Under Review
No
Next Planned Maintenance Review
Fall 2027
E&M Cycle Comments

Effective March 27, 2023, the National Quality Forum (NQF) is no longer the consensus-based entity (CBE) funded through the Centers for Medicare & Medicaid Services (CMS) National Consensus Development and Strategic Planning for Health Care Quality Measurement Contract. Battelle has been selected to oversee the endorsement & maintenance (E&M) of clinical quality and cost/resource use measures. Since the Fall 2022 cycle launched at NQF, measures submitted to this E&M cycle continued along the prior E&M protocols that were in place at time of the Fall 2022 “Intent to Submit.” Battelle took over the E&M work for the Fall 2022 cycle after developers and/or stewards submitted their full measure information to NQF, which for CBE #3719, the most recent measure specifications can be found here: https://p4qm.org/sites/default/files/2024-02/3719.zip

Battelle took over the E&M work beginning with the public comment period to close the E&M committees for the post-comment meeting, convening the CSAC to render a final endorsement decision, and executing the appeals period.

 

1.3 Measure Description
The PSWR measure tracks the number of prevalent dialysis patients in a practitioner (inclusive of physicians and advanced practice providers) group who are under the age of 75 and were listed on the kidney or kidney-pancreas transplant waitlist or received a living donor transplant. For each practitioner group, the Prevalent Standardized Waitlist Ratio (PSWR) is calculated to compare the observed number of waitlist events in a practitioner group to its expected number of waitlist events. The PSWR uses the expected waitlist events calculated from a Cox model, adjusted for patient age, incident and prevalent comorbidities, previous waitlisting and transplant, dual eligibility, Area Deprivation Index (ADI), and transplant center characteristics.
    • 1.5 Measure Type
      Outcome
    • 1.14 Numerator

      Number of prevalent dialysis patients in the practitioner group listed on the kidney or kidney-pancreas transplant waitlist or who received living donor transplants within each calendar year.

    • 1.15 Denominator

      The denominator for the PSWR is the expected number of waitlist or living donor transplant events in the practitioner group according to each patient’s treatment history, adjusted for patient age, incident and prevalent comorbidities, previous waitlisting and transplant, dual eligibility, Area Deprivation Index (ADI), and transplant center characteristics, among patients under 75 years of age.

    • 1.13a Data dictionary not attached
      No
      OLD 1.12 MAT output not attached
      Attached
    • Most Recent Endorsement Activity
      Not Endorsed Renal Fall 2022
      Initial Endorsement
      Last Updated
    • Risk adjustment approach
      Off
      Risk adjustment approach
      Off
      Conceptual model for risk adjustment
      Off
      Conceptual model for risk adjustment
      Off